Co-Diagnostics, Inc. — Director's Dealing 2021

Jan 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2021-01-07

Reporting Person: SERBIN RICHARD S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-07	Restricted Stock Units	$	A	37500	Acquired		Common Stock (37500)	Direct

Footnotes

F1: Granted pursuant to Issuer's 2015 Long Term Incentive Plan, as amended. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's common stock.

F2: RSU will vest in equal annual portions on: (i) January 7, 2021; (ii) January 7, 2022; and (iii) January 7, 2023.